Patents-Review.com
ClassID:

20462 ⎘

A61K31/5575 - page 2 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E, prostaglandin F

Recent Application in this class:
#301
20190381066
2019-12-19

Methods for treating scars and aging skin

 #302
20190374537
2019-12-12

LOW-DOSE BRIMONIDINE COMBINATIONS AND USES THEREOF

 #303
20190374478
2019-12-12

Ultrastable Gold Nanoparticles For Drug Delivery Applications And Synthesis Thereof

 #304
20190365652
2019-12-05

Poly(ketals) and related compositions and methods

 #305
20190336450
2019-11-07

OSMOTIC DRUG DELIVERY SYSTEM

 #306
20190330166
2019-10-31

Proxisome proliferator activated receptor (PPAR) compounds and methods of using the same

 #307
20190328698
2019-10-31

Esters for treatment of ocular inflammatory conditions

 #308
20190307769
2019-10-10

Hypotensive lipid-containing biodegradable intraocular implants and related methods

 #309
20190307768
2019-10-10

Ophthalmic composition for lowering intraocular pressure

 #310
20190298749
2019-10-03

METHODS AND PHARMACEUTICAL COMPOSITIONS COMPRISING A SGLT2 INHIBITOR FOR TREATING OR IMPROVING ERECTILE DYSFUNCTION

 #311
20190298735
2019-10-03

TREATMENT AND PREVENTION OF CLOSTRIDIUM DIFFICILE COLITIS USING MISOPROSTOL

 #312
20190290597
2019-09-26

DERMAL AND TRANSDERMAL ADMINISTRATION OF TREPROSTINIL AND SALTS THEREOF

 #313
20190269612
2019-09-05

Preservative free pharmaceutical compositions for ophthalmic administration

 #314
20190255068
2019-08-22

Prostacyclin analogue formulations

 #315
20190254965
2019-08-22

INTRACAMERAL SUSTAINED RELEASE THERAPEUTIC AGENT IMPLANTS

 #316
20190247277
2019-08-15

Preservative removal from eye drops

 #317
20190240234
2019-08-08

Pharmaceutical composition for treatment of increased intraocular pressure

 #318
20190240226
2019-08-08

Anti-proliferative agents for treating PAH

 #319
20190216727
2019-07-18

Punctal Plug With Active Agent

 #320
20190192536
2019-06-27

OIL-IN-WATER METHOD FOR MAKING POLYMERIC IMPLANTS CONTAINING A HYPOTENSIVE LIPID

 #321
20190175655
2019-06-13

DRY PLATELET COMPOSITION

 #322
20190175475
2019-06-13

COMPOSITIONS AND METHODS FOR TREATING HAIR LOSS USING NON-NATURALLY OCCURRING PROSTAGLANDINS

 #323
20190167696
2019-06-06

Method of treating hypertension

 #324
20190167695
2019-06-06

COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING MUSCLE CONDITIONS

 #325
20190160009
2019-05-30

LIPOSOMAL COMPOSITION CONTAINING MILD ACIDIC ACTIVE AGENT

 #326
20190151332
2019-05-23

Dry powder treprostinil for the treatment of pulmonary hypertension

 #327
20190151277
2019-05-23

USES OF BIOACTIVE LIPIDS

 #328
20190147147
2019-05-16

Analogs of proxisome proliferator activated receptor (PPAR) agonists and methods of using the same

 #329
20190143092
2019-05-16

Transdermal delivery of high viscosity bioactive agents

 #330
20190142842
2019-05-16

Ocular insert composition of a semi-crystalline or crystalline pharmaceutically active agent

 #331
20190117669
2019-04-25

Methods for Treating NSAID-Induced Cardiovascular, Cerebrovascular, or Renovascular Adverse Events

 #332
20190117562
2019-04-25

Preservative free pharmaceutical ophthalmic compositions

 #333
20190117450
2019-04-25

Preservative removal from eye drops

 #334
20190105265
2019-04-11

DRUG CORES FOR SUSTAINED RELEASE OF THERAPEUTIC AGENTS

 #335
20190105198
2019-04-11

Anterior segment drug delivery

 #336
20190091238
2019-03-28

J-series prostaglandin-ethanolamides as novel therapeutics for skin and/or oral disorders

 #337
20190091066
2019-03-28

Drug Delivery System and Methods of Treating Open Angle Glaucoma and Ocular Hypertension

 #338
20190083455
2019-03-21

METHODS AND COMPOSITIONS FOR THE MODULATION OF BETA-ENDORPHIN LEVELS

 #339
20190076529
2019-03-14

Prostaglandin compositions and methods for the treatment of vasospasm

 #340
20190076508
2019-03-14

Lysosomal acid lipase and PPAR gamma ligands as immune therapies for cancer treatment

 #341
20190076442
2019-03-14

PRESERVATIVE FREE PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC ADMINISTRATION CONTAINING BIMATOPROST AND TIMOLOL

 #342
20190060239
2019-02-28

Technology for the Preparation of Microparticles

 #343
20190054018
2019-02-21

Nasolacrimal drainage system implants for drug therapy

 #344
20190054017
2019-02-21

Drug delivery methods, structures, and compositions for nasolacrimal system

 #345
20190038636
2019-02-07

Use of medications with neuroprotective properties to prevent or reduce the risk of ischemia-reperfusion injury in a subject

 #346
20190029938
2019-01-31

Topical testosterone (T) for promoting hair growth—containing formulations

 #347
20190022105
2019-01-24

Treatment of migraines

 #348
20190021991
2019-01-24

OCULAR IMPLANTS CONFIGURED TO STORE AND RELEASE STABLE DRUG FORMULATIONS

 #349
20190015454
2019-01-17

Methods of treating ischemia

 #350
20190015404
2019-01-17

Kinase inhibitors for treatment of disease

 #351
20180353518
2018-12-13

OPHTHALMIC SOLUTIONS

 #352
20180353517
2018-12-13

METHODS AND COMPOSITIONS FOR REDUCING BODY FAT AND ADIPOCYTES

 #353
20180353504
2018-12-13

LOW-DOSE BRIMONIDINE COMBINATIONS AND USES THEREOF

 #354
20180344859
2018-12-06

NOVEL BIOMATERIALS AND A METHOD FOR MAKING AND USING SAME

 #355
20180344858
2018-12-06

NOVEL BIOMATERIALS AND A METHOD FOR MAKING AND USING SAME

 #356
20180344724
2018-12-06

Combination therapy

 #357
20180333405
2018-11-22

Combination therapy

 #358
20180333377
2018-11-22

Methods and compositions for treating Raynaud's disease

 #359
20180318319
2018-11-08

Compositions and Methods for Treating Eyes and Methods of Preparation

 #360
20180311233
2018-11-01

Pharmaceutical combination of opioid and prostaglandin compound

 #361
20180303905
2018-10-25

Use of immunomodulatory kits for immunotherapeutic treatment of patients with myeloid leukemias

 #362
20180303849
2018-10-25

Pharmaceutical composition for treatment of increased intraocular pressure

 #363
20180303752
2018-10-25

Implants with controlled drug delivery features and methods of using same

 #364
20180296570
2018-10-18

TOPICAL COMPOSITIONS COMPRISING BIMATOPROST AND METHODS FOR STIMULATING HAIR GROWTH THEREWITH

 #365
20180289810
2018-10-11

Sustained release eye drop formulations

 #366
20180289719
2018-10-11

COMPOSITION

 #367
20180289618
2018-10-11

Method and composition for treating ocular hypertension and glaucoma

 #368
20180280313
2018-10-04

Methods and biocompatible compositions to achieve sustained drug release in the eye

 #369
20180271878
2018-09-27

PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANTS AND METHODS OF USE THEREOF

 #370
20180250215
2018-09-06

Topical application of dihydrotestosterone and testosterone fixed combination formulation for promoting hair growth containing formulations

 #371
20180250214
2018-09-06

Topical dihydrotestosterone (DHT) for promoting hair growth-containing formulations

 #372
20180228814
2018-08-16

COMPOSITIONS & METHODS FOR LOWERING INTRAOCULAR PRESSURE

 #373
20180228724
2018-08-16

Drippable opthalmic bimatoprost gel

 #374
20180207293
2018-07-26

NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE

 #375
20180207174
2018-07-26

Hypotensive lipid-containing biodegradable intraocular implants and related methods

 #376
20180200372
2018-07-19

Compositions and methods for topical delivery of prostaglandins to subcutaneous fat

 #377
20180200264
2018-07-19

Compositions and Methods for Muscle Regeneration Using Prostaglandin E2

 #378
20180193354
2018-07-12

TREATMENT OF MIGRAINES

 #379
20180185385
2018-07-05

Preservative free bimatoprost and timolol solutions

 #380
20180185384
2018-07-05

DRUG THERAPY FOR PREVENTING OR TREATING GLAUCOMA

 #381
20180177799
2018-06-28

Compositions and methods for muscle regeneration using prostaglandin E2

 #382
20180177798
2018-06-28

COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH

 #383
20180169111
2018-06-21

Methods and compositions for topical delivery of prostaglandins to subcutaneous fat

 #384
20180153903
2018-06-07

Oil-in-water method for making polymeric implants containing a hypotensive lipid

 #385
20180147214
2018-05-31

DO stabilized pharmaceutical formulations

 #386
20180133150
2018-05-17

Nasolacrimal drainage system implants for drug therapy

 #387
20180125804
2018-05-10

Synergistic famciclovir and celecoxib combination therapy for functional somatic syndromes

 #388
20180118677
2018-05-03

Nitric oxide donating derivatives of fluprostenol

 #389
20180118676
2018-05-03

Nitric oxide donating derivatives of latanoprost free acid

 #390
20180104268
2018-04-19

METHODS AND PHARMACEUTICAL COMPOSITIONS COMPRISING A SGLT2 INHIBITOR FOR TREATING OR IMPROVING ERECTILE DYSFUNCTION

 #391
20180104255
2018-04-19

Compositions and methods for reducing body fat

 #392
20180092927
2018-04-05

TOPICAL FORMULATIONS AND USES THEREOF

 #393
20180092926
2018-04-05

Bimatoprost Ocular Silicone Inserts and Methods of Use Thereof

 #394
20180055833
2018-03-01

Ophthalmic compositions

 #395
20180028449
2018-02-01

Technology for the Preparation of Microparticles

 #396
20180021348
2018-01-25

Hypotensive lipid-containing biodegradable intraocular implants and related implants

 #397
20180021347
2018-01-25

COMPOSITION FOR THE TREATMENT OF HEPATIC VENO-OCCLUSIVE DISEASE

 #398
20180012002
2018-01-11

Analogs of proxisome proliferator activated receptor (PPAR) agonists and methods of using the same

 #399
20180008674
2018-01-11

Use Of Immunomodulatory Effective Kits For The Immunotherapeutic Treatment Of Patients Suffering From Myeloid Leukemias

 #400
20180003713
2018-01-04

Non-invasive biomarker to identify subject at risk of preterm delivery

 #401
20170369416
2017-12-28

Controlled release pharmaceutical formulations

 #402
20170368075
2017-12-28

COMPOSITION

 #403
20170367992
2017-12-28

Drug delivery system for delivery of acid sensitivity drugs

 #404
20170354634
2017-12-14

Combinations of prostaglandins and nitric oxide donors

 #405
20170354615
2017-12-14

PHARMACEUTICAL PREPARATION

 #406
20170348214
2017-12-07

COMPOSITIONS AND METHODS FOR TREATING HAIR LOSS USING NON-NATURALLY OCCURRING PROSTAGLANDINS

 #407
20170340647
2017-11-30

Preservative-free treprostinil formulations and methods and devices for use with same

 #408
20170326094
2017-11-16

USES OF BIOACTIVE LIPIDS

 #409
20170319590
2017-11-09

Pharmaceutical formulations of xanthine or xanthine derivatives, and their use

 #410
20170304316
2017-10-26

Ophthalmic solution

 #411
20170304194
2017-10-26

DRUG CORES FOR SUSTAINED RELEASE OF THERAPEUTIC AGENTS

 #412
20170296483
2017-10-19

Methods and biocompatible compositions to achieve sustained drug release in the eye

 #413
20170283385
2017-10-05

Proxisome proliferator activated receptor (PPAR) compounds and methods of using the same

 #414
20170281613
2017-10-05

Combination therapy

 #415
20170281584
2017-10-05

Misoprostol Dispersible Tablet

 #416
20170266201
2017-09-21

Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods

 #417
20170266200
2017-09-21

Methods for delivering a bio-active agent or bio-active agents to an eye of a mammal

 #418
20170252354
2017-09-07

Compositions and methods for muscle regeneration using prostaglandin E2

 #419
20170246175
2017-08-31

SUSTAINED TIMOLOL MALEATE DELIVERY FROM LIPOSOMES FOR GLAUCOMA THERAPY AND OCCULAR HYPERTENSION

 #420
20170246134
2017-08-31

Famciclovir and celecoxib combination therapy for functional somatic syndromes

 #421
20170239268
2017-08-24

Prostaglandin conjugates and derivatives for treating glaucoma and ocular hypertension

 #422
20170232001
2017-08-17

METHOD AND COMPOSITION FOR TREATING MIGRAINES

 #423
20170224531
2017-08-10

Preservative removal from eye drops

 #424
20170216309
2017-08-03

Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseases

 #425
20170216308
2017-08-03

Polymer conjugate for delivery of a bioactive agent

 #426
20170202853
2017-07-20

Sustained release delivery of active agents to treat glaucoma and ocular hypertension

 #427
20170202852
2017-07-20

Topical dosage regimen

 #428
20170189535
2017-07-06

Compound prescription colloidal eyedrop gel and methods of making the same

 #429
20170189395
2017-07-06

Diketopiperazine microparticles with defined specific surface areas

 #430
20170182173
2017-06-29

Polymer conjugate for delivery of a bioactive agent

 #431
20170173046
2017-06-22

Injectable Osteogenic Formulations, and Methods of Use Thereof

 #432
20170173045
2017-06-22

Misoprostol dispersible tablet

 #433
20170172916
2017-06-22

PUNCTAL PLUG WITH ACTIVE AGENT

 #434
20170165112
2017-06-15

TRANS-SCLERA PORTAL FOR DELIVERY OF THERAPEUTIC AGENTS

 #435
20170165111
2017-06-15

TRANS-SCLERA PORTAL FOR DELIVERY OF THERAPEUTIC AGENTS

 #436
20170157111
2017-06-08

HIF inhibitors and use thereof

 #437
20170151273
2017-06-01

OPHTHALMIC FORMULATIONS

 #438
20170151261
2017-06-01

SKIN WOUND HEALING AND SCAR REDUCTION WITH PROSTAGLANDIN EP4 AGONIST COMBINATIONS

 #439
20170136064
2017-05-18

Dry platelet composition

 #440
20170136032
2017-05-18

Methods and compositions for treating metabolic syndrome

 #441
20170128707
2017-05-11

Transdermal delivery of high viscosity bioactive agents

 #442
20170128362
2017-05-11

APPLICATION OF LARGE-DOSE GLYCERINUM IN FREEZE-THAWING TOLERABLE LIPID EMULSION

 #443
20170128361
2017-05-11

Nasolacrimal drainage system implants for drug therapy

 #444
20170112854
2017-04-27

Misoprostol Composition

 #445
20170112853
2017-04-27

Hypotensive lipid and timolol compositions and methods of using same

 #446
20170105931
2017-04-20

Pharmaceutical compositions comprising gels and methods for fabricating thereof

 #447
20170100410
2017-04-13

Use of medications with neuroprotective properties to prevent or reduce the risk of ischemia-reperfusion injury in a subject

 #448
20170095417
2017-04-06

Percutaneous Implement and Method for Manufacturing

 #449
20170087164
2017-03-30

METHOD AND COMPOSITION FOR ENHANCEMENT OF MALE ERECTILE FUNCTION

 #450
20170071953
2017-03-16

Microsphere Drug Delivery System for Sustained Intraocular Release

 #451
20170071853
2017-03-16

Intracameral sustained release therapeutic agent implants

 #452
20170065667
2017-03-09

METHODS FOR SYNCHRONIZATION OF ESTROUS CYCLES AND OVULATION FOR FIXED TIME ARTIFICIAL INSEMINATION IN CATTLE

 #453
20170065612
2017-03-09

Hypotensive lipid-containing biodegradable intraocular implants and related implants

 #454
20170065611
2017-03-09

TOPICAL FORMULATIONS AND USES THEREOF

 #455
20170065610
2017-03-09

Compositions and methods for lowering intraocular pressure

 #456
20170056412
2017-03-02

Prostamide-containing intraocular implants and methods of use thereof

 #457
20170056242
2017-03-02

Anterior segment drug delivery

 #458
20170049851
2017-02-23

Method for Medical Treatment

 #459
20170049799
2017-02-23

OPHTHALMIC FORMULATIONS

 #460
20170049793
2017-02-23

MOLECULAR ACTIVATORS OF THE WNT/BETA-CATENIN PATHWAY

 #461
20170042908
2017-02-16

METHOD FOR TREATING GEOGRAPHIC ATROPHY ASSOCIATED WITH AGE-RELATED MACULAR DEGENERATION

 #462
20170035859
2017-02-09

Methods and compositions for treating nephrogenic diabetes insipidus

 #463
20170035779
2017-02-09

Topical compositions comprising bimatoprost and methods for stimulating hair growth therewith

 #464
20170028078
2017-02-02

SUSTAINED-RELEASE DRUG FORMULATIONS FOR GLAUCOMA

 #465
20170020889
2017-01-26

DRUG THERAPY FOR PREVENTING OR TREATING GLAUCOMA

 #466
20160367640
2016-12-22

Rapid-acting insulin compositions

 #467
20160367586
2016-12-22

COMBINATION, KIT AND METHOD OF REDUCING INTRAOCULAR PRESSURE

 #468
20160361386
2016-12-15

Methods and compositions for inducing differentiation of human brown adipocyte progenitors

 #469
20160354386
2016-12-08

Compositions and methods for reducing body fat

 #470
20160354385
2016-12-08

Method to enhance tissue regeneration

 #471
20160354384
2016-12-08

ENHANCED BIMATOPROST OPHTHALMIC SOLUTION

 #472
20160354383
2016-12-08

Prostaglandin and vasoconstrictor pharmaceutical compositions and methods of use

 #473
20160354309
2016-12-08

OCULAR IMPLANTS CONFIGURED TO STORE AND RELEASE STABLE DRUG FORMULATIONS

 #474
20160346269
2016-12-01

Combination therapy

 #475
20160346183
2016-12-01

Compositions for reducing hair loss and/or increasing hair regrowth

 #476
20160339039
2016-11-24

Sustained release bimatoprost, bimatoprost analogs, prostamides and prostaglandins for fat reduction

 #477
20160331761
2016-11-17

Methods and compositions for treating Raynaud's disease

 #478
20160331735
2016-11-17

NOVEL FORMULATIONS FOR TREATMENT OF PAIN, NEUROPATHY, WOUNDS, AND ULCERS

 #479
20160324871
2016-11-10

Hypotensive lipid-containing biodegradable intraocular implants and related methods

 #480
20160324870
2016-11-10

Treatment of migraines

 #481
20160310439
2016-10-27

Lipid microcapsules preferably comprising a retinoid, and composition containing same, method for the production thereof, and use of same in dermatology

 #482
20160310417
2016-10-27

Formulations and Methods For Targeted Ocular Delivery of Therapeutic Agents

 #483
20160303145
2016-10-20

Small molecules that promote skin regeneration

 #484
20160303005
2016-10-20

Lipid microcapsules preferably comprising a lipophilic active substance and composition containing same, method for the production thereof, and use of same in dermatology and in cosmetics

 #485
20160302965
2016-10-20

IMPLANTABLE THERAPEUTIC DEVICES

 #486
20160296627
2016-10-13

INTRACAMERAL IMPLANT FOR TREATMENT OF AN OCULAR CONDITION

 #487
20160296532
2016-10-13

Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent

 #488
20160279143
2016-09-29

TOPICAL TREATMENT FOR CHEMOTHERAPY INDUCED EYELASH LOSS OR HYPOTRICHOSIS USING PROSTAMIDE F2 ALPHA AGONISTS

 #489
20160263042
2016-09-15

Osmotic drug delivery system

 #490
20160263023
2016-09-15

Preservative free pharmaceutical compositions for ophthalmic administration

 #491
20160263022
2016-09-15

Hypotensive prostamide-containing biodegradable intraocular implants and related implants

 #492
20160256382
2016-09-08

SUSTAINED-RELEASE RESERVOIR IMPLANTS FOR INTRACAMERAL DRUG DELIVERY

 #493
20160250225
2016-09-01

ENHANCED BIMATOPROST OPHTHALMIC SOLUTION

 #494
20160243131
2016-08-25

Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods

 #495
20160243105
2016-08-25

Combination therapy

 #496
20160235675
2016-08-18

Technology for the Preparation of Microparticles

 #497
20160228453
2016-08-11

Prostaglandin F2Alpha and analogues thereof for treating atrophic cutaneous scarring

 #498
20160228421
2016-08-11

COMPOSITION FOR TREATING OR PREVENTING GLAUCOMA COMPRISING A SULFONAMIDE COMPOUND AND ANOTHER DRUG

 #499
20160213590
2016-07-28

Compositions for reducing hair loss and/or increasing hair regrowth

 #500
20160206626
2016-07-21

TOPICAL COMPOSITIONS COMPRISING BIMATOPROST AND METHODS FOR STIMULATING HAIR GROWTH THEREWITH

 #501
20160206556
2016-07-21

Biodegradable ocular implant

 #502
20160199386
2016-07-14

Methods of treating thyroid eye disease

 #503
20160199381
2016-07-14

Inhibition of thymine DNA glycosylase in the treatment of cancer

 #504
20160199277
2016-07-14

Compositions and methods for stimulating hair growth

 #505
20160177298
2016-06-23

Channel modulators

 #506
20160175449
2016-06-23

Biomaterials and a method for making and using same

 #507
20160175320
2016-06-23

Compositions, methods and kits for treating cancer

 #508
20160175319
2016-06-23

Composition for the treatment of cystic fibrosis

 #509
20160151496
2016-06-02

Sustained release eye drop formulations

 #510
20160151386
2016-06-02

Sustained release formulations for the treatment of intraocular pressure or glaucoma

 #511
20160129087
2016-05-12

Rapid-acting insulin compositions

 #512
20160113942
2016-04-28

COMPOSITIONS COMPRISING A PROSTAGLANDIN FOR TREATING NEUROPSYCHIATRIC CONDITIONS

 #513
20160108404
2016-04-21

Method for inhibiting HIV replication in mammal and human cells

 #514
20160108012
2016-04-21

Prostaglandin conjugates and derivatives for treating glaucoma and ocular hypertension

 #515
20160106757
2016-04-21

OPHTHALMIC SOLUTIONS

 #516
20160106651
2016-04-21

Compositions and methods for treating hair loss using non-naturally occurring prostaglandins

 #517
20160096817
2016-04-07

Treatment of inflammatory bowel disease

 #518
20160081954
2016-03-24

Methods and compositions for treating raynaud's disease

 #519
20160067263
2016-03-10

Methods and compositions for topical delivery of prostaglandins to subcutaneous fat

 #520
20160067225
2016-03-10

Aromatase inhibitor-releasing intravaginal device

 #521
20160051562
2016-02-25

Methods for reducing body fat using tafluprost and analogs thereof

 #522
20160039835
2016-02-11

Organic compounds

 #523
20160031895
2016-02-04

Organic compounds

 #524
20160030355
2016-02-04

Osmotic drug delivery system

 #525
20160022695
2016-01-28

Bimatoprost Ocular Silicone Inserts and Methods of Use Thereof

 #526
20160022678
2016-01-28

Therapeutic compositions containing macitentan

 #527
20160022614
2016-01-28

Compositions and methods for treating cancer

 #528
20160022581
2016-01-28

Processes for making cyclic lipid implants for intraocular use

 #529
20160016920
2016-01-21

Analogs of peroxisome proliferator activated receptor (PPAR) agonists, and methods of using the same

 #530
20160015718
2016-01-21

Oil-in-water method for making polymeric implants containing a hypotensive lipid

 #531
20160015717
2016-01-21

ENHANCED BIMATOPROST OPHTHALMIC SOLUTION

 #532
20160008171
2016-01-14

Scleral and conjuctival implants for drug therapy

 #533
20160000929
2016-01-07

Polymer conjugate for delivery of a bioactive agent

 #534
20150359801
2015-12-17

Compositions and methods for reducing body fat

 #535
20150342961
2015-12-03

USE OF PROSTAGLANDIN E1 (PGE1) AND MISOPROSTOL FOR TREATING CHRONIC MYELOGENOUS/MYELOID LEUKEMIA (CML)

 #536
20150342875
2015-12-03

IMPLANTS WITH CONTROLLED DRUG DELIVERY FEATURES AND METHODS OF USING SAME

 #537
20150328232
2015-11-19

PROSTACYLIN COMPOSITIONS AND METHODS FOR USING THE SAME

 #538
20150328108
2015-11-19

Compositions and methods for stimulating hair growth

 #539
20150320764
2015-11-12

TREATING FEMALE SEXUAL AROUSAL DISORDER AND RELATED SYMPTOMS

 #540
20150320760
2015-11-12

Valaciclovir and meloxicam combination therapy for functional somatic syndromes

 #541
20150297731
2015-10-22

THERMOSENSITIVE INJECTABLE GLAUCOMA DRUG CARRIER GEL AND THE FABRICATING METHOD THEREOF

 #542
20150290216
2015-10-15

Ophthalmic composition comprising a prostaglandin

 #543
20150285800
2015-10-08

Non-invasive biomarker to identify subject at risk of preterm delivery

 #544
20150283150
2015-10-08

Intracameral sustained release therapeutic agent implants

 #545
20150272963
2015-10-01

Compositions, methods and kits for treating cancer

 #546
20150272961
2015-10-01

METHOD FOR TREATING MUCOSITIS, METHOD FOR TREATING TUMOR, AND PHARMACEUTICAL COMBINATION

 #547
20150272898
2015-10-01

Method of making oil-in-oil emulsified polymeric implants containing a hypotensive lipid

 #548
20150272875
2015-10-01

ALPROSTADIL FOR TREATMENT OF PREMATURE EJACULATION

 #549
20150272834
2015-10-01

Compostions and methods for enhancing the topical application of a basic benefit agent

 #550
20150265629
2015-09-24

USE OF ELECTROPHILIC COMPOUNDS FOR INDUCING PLATELET PRODUCTION OR MAINTAINING PLATELET FUNCTION

 #551
20150250891
2015-09-10

Hyaluronic acid-based drug delivery systems

 #552
20150238414
2015-08-27

Misoprostol Formulation

 #553
20150231251
2015-08-20

Methods for topical delivery of prostaglandins to subcutaneous fat

 #554
20150224200
2015-08-13

Drug Delivery Methods, Structures, and Compositions for Nasolacrimal Systems

 #555
20150224115
2015-08-13

Preservative free bimatoprost and timolol solutions

 #556
20150196516
2015-07-16

Pharmaceutical formulations for the treatment of pulmonary arterial hypertension

 #557
20150190359
2015-07-09

Stable liposomal formulations for ocular drug delivery

 #558
20150174139
2015-06-25

Misoprostol Composition

 #559
20150157642
2015-06-11

COSMETIC METHOD FOR CHANGING THE APPEARANCE OF EYES

 #560
20150157563
2015-06-11

Ocular composition and method

 #561
20150150886
2015-06-04

Compositions, methods and kits for treating cancer

 #562
20150150880
2015-06-04

Hypotensive lipid and timolol compositions and methods of using same

 #563
20150126609
2015-05-07

Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound

 #564
20150118279
2015-04-30

Prostamide-containing intraocular implants and methods of use thereof

 #565
20150111969
2015-04-23

J-series prostaglandin-ethanolamides as novel therapeutics

 #566
20150111881
2015-04-23

Acyclovir and meloxicam combination therapy for functional somatic syndromes

 #567
20150105462
2015-04-16

Compositions for topical delivery of prostaglandins to subcutaneous fat

 #568
20150099807
2015-04-09

PRESERVATIVE FREE BIMATOPROST SOLUTIONS

 #569
20150099805
2015-04-09

Hypotensive lipid-containing biodegradable intraocular implants and related methods

 #570
20150099703
2015-04-09

TREATMENT OF POSTPARTUM HAEMORRHAGE WITH CHEMICALLY MODIFIED HEPARIN OR HEPARAN SULPHATE AND A UTEROTONIC AGENT

 #571
20150080357
2015-03-19

ORGANIC COMPOUNDS

 #572
20150079170
2015-03-19

Tablet dosage form

 #573
20150072999
2015-03-12

Method to treat functional somatic syndromes with combination of aciclovir and celecoxib

 #574
20150051259
2015-02-19

Pro-inflammatory mediators in diagnosis and treatment of chronic obstructive pulmonary disease

 #575
20150045322
2015-02-12

COMBINATION TREATMENT COMPRISING SULPHATED GLYCOSAMINOGLYCANS FOR INDUCING LABOR

 #576
20150038474
2015-02-05

ORGANIC COMPOUNDS

 #577
20150025255
2015-01-22

Process for preparing synthetic prostacyclins

 #578
20150025151
2015-01-22

Compositions and methods for reducing body fat

 #579
20150025150
2015-01-22

Methods for reducing body fat

 #580
20150025020
2015-01-22

Self-preserved oil dispersions comprising boric acid

 #581
20150023868
2015-01-22

HIF inhibitors and use thereof

 #582
20150018423
2015-01-15

Injectable osteogenic formula and method of using same

 #583
20150018400
2015-01-15

Treatment of inflammatory bowel disease

 #584
20150017151
2015-01-15

Pharmaceutical formulations of xanthine or xanthine derivatives, and their use

 #585
20150011638
2015-01-08

Alprostadil and lidocaine treatment of premature ejaculation

 #586
20150011587
2015-01-08

Alprostadil for treatment of premature ejaculation

 #587
20150011585
2015-01-08

Alprostadil and dyclonine for treatment of premature ejaculation

 #588
20150011571
2015-01-08

Valaciclovir and celecoxib combination for functional somatic syndromes

 #589
20150004243
2015-01-01

Microparticles manufactured in an oil-in-water process comprising a prostamide

 #590
20140371309
2014-12-18

OPHTHALMIC SOLUTION

 #591
20140364400
2014-12-11

Esters for treatment of ocular inflammatory conditions

 #592
20140350482
2014-11-27

RECONSTITUTION DEVICE

 #593
20140350104
2014-11-27

Tafluprost and analogs thereof for reducing fat

 #594
20140348802
2014-11-27

Methods of treating ischemia

 #595
20140335056
2014-11-13

Sustained releasing pharmaceutical composition

 #596
20140329824
2014-11-06

Therapeutic compositions containing macitentan

 #597
20140323567
2014-10-30

Controlled release pharmaceutical formulations

 #598
20140314868
2014-10-23

Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof

 #599
20140309195
2014-10-16

Small molecules that promote skin regeneration

 #600
20140308354
2014-10-16

SUSTAINED RELEASE BIMATOPROST, BIMATOPROST ANALOGS, PROSTAMIDES AND PROSTAGLANDINS FOR FAT REDUCTION